AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8847861
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg diltiazem OD
Trial: 8847861
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg diltiazem OD
Trial: 8847861
Drug: 420 mg
RxNorm normalized name: choline 420 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 420 mg diltiazem OD
Trial: 27042750
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH (rhGH) treatment with 25(OH)D below the 50th percentile
Trial: 22454414
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m² IV over 1 hour for 21 days plus prednisone 5 mg orally twice per day (DP)
Trial: 12490735
Drug: Fulvestrant 250
RxNorm normalized name: fulvestrant 250 MG in 5 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant 250 mg monthly by intramuscular injection
Trial: 31969301
Drug: Simvastatin 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 1% gel
Trial: 22004512
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 2 kcal/min (G2)
Trial: 22004512
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 4 kcal/min (G4)
Trial: 22004512
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 1 kcal/min (G1)
Trial: 9734735
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion
Trial: 19223626
Drug: EDP-420 (100-1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDP-420 (100-1200 mg)
Trial: 19223626
Drug: EDP-420 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDP-420 (400 mg)
Trial: 17961376
Drug: Selective‐adrenoceptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective‐adrenoceptor antagonists (terazosin, doxazosin, tamsulosin, naftopidil)
Trial: 17961376
Drug: 5 alpha‐reductase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 alpha‐reductase inhibitors (finasteride, epristeride)
Trial: 12486870
Drug: Calcium (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1000 mg elemental calcium per day for 2 months)
Trial: 9655592
Drug: Combination teaching
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination teaching approach
Trial: 7864689
Drug: disease modifying
FDA approved: no
EMA approved: no
PMDA approved: no
Description: disease modifying antirheumatic drug therapy
Trial: 15309445
Drug: Plain release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain release vitamin C (2 x 250 mg daily) with vitamin E (2 x 91 mg)
Trial: 15079004
Drug: Triflusal 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflusal 600 mg daily
Trial: 20117379
Drug: Aspirin 325
RxNorm normalized name: aspirin 325 MG
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin 325 mg daily
Trial: 419761
Drug: Hexestrol treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hexestrol treatment for 12 months or longer
Trial: 26088721
Drug: Fentanyl iontophoretic
RxNorm normalized name: fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl iontophoretic transdermal system (ITS) 40 μg/dose
Trial: 19912069
Drug: Oral PR
RxNorm normalized name: Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PR oxycodone/naloxone
Trial: 19912069
Drug: Oral PR
RxNorm normalized name: Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PR oxycodone
Trial: 15034826
Drug: Oral azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral azithromycin (20 mg/kg per day; maximum dose, 1000 mg/day) for 5 days
Trial: 15034826
Drug: Intravenous ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ceftriaxone (75 mg/day; maximum dose, 2.5 g/day) for 5 days
Trial: 25799808
Drug: Amoxicillin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (40 mg/kg/day) for 7 days
Trial: 19231545
Drug: Real interferential
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real interferential therapy (IFT) sessions, 12 sessions over a 4-week period.
Trial: 15179026
Drug: Ayahuasca (0.85
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ayahuasca (0.85 mg DMT/kg body weight)
Trial: 31340842
Drug: 4CMenB booster
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB booster dose
Trial: 30691980
Drug: 2 catch-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 catch-up doses of 4CMenB (vaccine-naïve)
Trial: 30691980
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (Primed_4y and Primed_7.5y)
Trial: 30691980
Drug: 4CMenB vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4CMenB vaccine (Naïve_4y and Naïve_7.5y)
Trial: 21636012
Drug: Nutritional supplementation
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplementation of hop rho iso-alpha acids (200 mg), berberine sulfate trihydrate (100 mg), vitamin D₃ (500 IU), and vitamin K₁ (500 μg) twice daily
Trial: 17651103
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine infusion (10 microg/kg/min)
Trial: 24843963
Drug: Acupuncture-moxibustion therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture-moxibustion therapy
Trial: 11475729
Drug: Qianliekang tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qianliekang tablets (Control)
Trial: 8549036
Drug: Rifampin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin (600 mg once daily for 5 days)
Trial: 3888857
Drug: Oxyfedrine (8-24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxyfedrine (8-24 mg three times a day)
Trial: 3888857
Drug: Propranolol (40-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40-80 mg three times a day)
Trial: 26062785
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg memantine
Trial: 24940052
Drug: Calcium fructoborate
RxNorm normalized name: CALCIUM FRUCTOBORATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium fructoborate (CFB) 110 mg twice per day
Trial: 18070439
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose midazolam sedation
Trial: 15681985
Drug: Emotional and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emotional and educational intervention focusing on recurrence of breast cancer, 4 weeks duration, weekly meetings
Trial: 10588463
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg of warfarin daily in combination with 75 mg of aspirin
Trial: 8921777
Drug: Baseline HDL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline HDL cholesterol (1.39 mmol/L) and triglycerides (1.62 mmol/L for fasting participants)
Trial: 8921777
Drug: Fasting participants
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting participants with triglycerides < 4.52 mmol/L
Trial: 1495150
Drug: Silver sulfadiazine
RxNorm normalized name: Silver Sulfadiazine
DrugBank: Silver sulfadiazine (DB05245)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver sulfadiazine 1% cream
Trial: 1495150
Drug: Biologically active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologically active tripeptide copper complex 0.4% cream
Trial: 16763388
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone provocation test
Trial: 16763388
Drug: D-xylose absorption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-xylose absorption test and fecal fat measurement
Trial: 11513909
Drug: Hydroxychloroquine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (200 or 400 mg depending on bodyweight)
Trial: 8290452
Drug: HAD Hand
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAD Hand Wash (povidone-iodine alcoholic disinfectant solution)
Trial: 8290452
Drug: Benzalkonium chloride
RxNorm normalized name: Benzalkonium Chloride
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzalkonium chloride alcoholic lotion
Trial: 29624463
Drug: Adjuvant androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant androgen deprivation therapy (ADT)
Trial: 29624463
Drug: Adjuvant androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant androgen deprivation therapy (ADT) plus mitoxantrone and prednisone (MP)
Trial: 2107242
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered for 8 weeks
Trial: 19432501
Drug: Olmesartan 40
RxNorm normalized name: HCTZ 25/OLMESARTAN 40MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 40 mg plus Amlodipine 5 mg or 10 mg
Trial: 19432501
Drug: Olmesartan 40
RxNorm normalized name: HCTZ 25/OLMESARTAN 40MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 40 mg plus Amlodipine 10 mg
Trial: 15784799
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (single dose of vitamin E)
Trial: 12436823
Drug: Local delivery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local delivery of antimicrobial agents
Trial: 3336109
Drug: Systemic antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antimicrobial agents
Trial: 9745150
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution (LRS) 1,500 ml at 25 ml/min
Trial: 9745150
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch (HES) 500 ml at 25 ml/min
Trial: 7821060
Drug: High-dose radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose radiation therapy (5 fractions of 3.5 Gy each)
Trial: 2568015
Drug: H2-receptor antagonists
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H2-receptor antagonists
Trial: 25415737
Drug: Small doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small doxorubicin drug-eluting beads (100-300 µm)
Trial: 25415737
Drug: Large doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large doxorubicin drug-eluting beads (300-500 and 500-700 µm)
Trial: 20881754
Drug: Nizatidine controlled
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine controlled release (CR) 150 mg
Trial: 20881754
Drug: Nizatidine controlled
RxNorm normalized name: Nizatidine
DrugBank: Nizatidine (DB00585)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nizatidine controlled release (CR) 300 mg
Trial: 15840681
Drug: CsA microemulsion,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA microemulsion, steroids, mycophenolate sodium and basiliximab
Trial: 11832356
Drug: Acetaminophen (ACET;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (ACET; 4,000 mg/day)
Trial: 7772487
Drug: Topical cyclosporin
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporin (CyA) 500 mg as a swish-and-spit medication for 5 min three times daily for 6 weeks
Trial: 7772487
Drug: Corticosteroid oral
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid oral paste (triamcinolone acetonide) for 6 weeks
Trial: 25125716
Drug: Standard doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard doses of testosterone
Trial: 18182868
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation program (2 sessions, 2 hours daily for 5 days)
Trial: 9506749
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose flunisolide (H FN, 2000 microg/day)
Trial: 7534320
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (Norditropin, 4 I.U. twice daily) for 6 weeks
Trial: 8319375
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone
Trial: 7036400
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg sublingually
Trial: 30169980
Drug: Melatonin solution
RxNorm normalized name: melatonin Oral Solution
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin solution
Trial: 10331397
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion after exercise
Trial: 30987551
Drug: Alpha lipoic
RxNorm normalized name: Alpha Lipoic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha lipoic acid (ALA) 600 mg daily for 8 weeks
Trial: 25942341
Drug: Stem cells
RxNorm normalized name: Stem cells, apheresis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stem cells in combination with bioresorbable PLA/PGA membrane
Trial: 16449111
Drug: 4% intrauterine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% intrauterine lidocaine infusion
Trial: 17167254
Drug: 20% sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% sucrose solution exposure 8 times/day
Trial: 17167254
Drug: 20% sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20% sucrose solution exposure 10 times/day
Trial: 10075384
Drug: Isoflavonoid supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavonoid supplement (55 mg daily including 30 mg genistein, 16 mg biochanin A, 1 mg daidzein, 8 mg formononetin)
Trial: 10075384
Drug: Isoflavonoid supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoflavonoid supplement
Trial: 7719894
Drug: Turbuhaler inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler inhalation of terbutaline (0.125, 0.25, 0.5, 1.0, 2.0 mg doses)
Trial: 7719894
Drug: Pressurized metered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurized metered dose inhaler inhalation of terbutaline (0.125, 0.25, 0.5, 1.0, 2.0 mg doses)
Trial: 7719894
Drug: Turbuhaler and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turbuhaler and Pressurized metered dose inhaler
Trial: 1827311
Drug: Spiroplatin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiroplatin at 30 mg/m2 by 4 h infusion every 3 weeks (recommended dose for phase II studies)
Trial: 1827311
Drug: Spiroplatin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiroplatin at 35 mg/m2 (MTD for poor-risk patients)
Trial: 1827311
Drug: Spiroplatin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiroplatin at 40 mg/m2 (MTD for good-risk patients)
Trial: 1827311
Drug: Spiroplatin (dose-dependent)
RxNorm normalized name: Picoplatin
DrugBank: Picoplatin (DB04874)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spiroplatin (dose-dependent)
Trial: 7479625
Drug: 2‐mg nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐mg nicotine gum
Trial: 11082826
Drug: 4‐mg nicotine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4‐mg nicotine gum
Trial: 25195060
Drug: Betamethasone (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betamethasone (8 mg intravenously before surgery)
Trial: 9644112
Drug: PGE1 infusion
RxNorm normalized name: PGE1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PGE1 infusion (30 micrograms/h for 2-6 h)
Trial: 7840523
Drug: Tamoxifen alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen alone (loading dose of 160 mg on the first day)
Trial: 31920008
Drug: Chemotherapy in
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy in EGFR-negative tumors
Trial: 17698986
Drug: Lipid/heparin-somatostatin-insulin-glucagon clamps
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid/heparin-somatostatin-insulin-glucagon clamps
Trial: 2665305
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment of ulcers
Trial: 989965
Drug: High molecular
RxNorm normalized name: dextran, high molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High molecular weight sodium heparin (mean m.w. 22,000)
Trial: 24192751
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg telaprevir (TVR) at 8 h intervals
Trial: 24192751
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg telaprevir (TVR) at 12 h intervals
Trial: 19081706
Drug: Human growth
RxNorm normalized name: Human growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human growth hormone (0.1 mg . kg(‐1) . d(‐1))
Trial: 10787112
Drug: Subcutaneous placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous placebo
Trial: 17225037
Drug: Therapy by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy by therapists
Trial: 17225037
Drug: Daily therapy
RxNorm normalized name: Konsyl Daily Therapy Fiber Laxative 625mg Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily therapy by more than one therapist
Trial: 17225037
Drug: Upper-limb therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upper-limb therapy
Trial: 17225037
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of family members during therapy
Trial: 12482192
Drug: 4 doses
RxNorm normalized name: parathyroid hormone 25 MCG/Dose Cartridge, 14 Doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 doses of the HiB vaccine (PPR‐D, Connaught) starting at 3 months of life
Trial: 12482192
Drug: 0 doses
RxNorm normalized name: mometasone furoate 220 mcg/actuation (30 doses) INHALATION AEROSOL POWDER, BREATH ACTIVATED (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 doses of the HiB vaccine (control group)
Trial: 9935122
Drug: Dexamethasone 9
RxNorm normalized name: DEXAMETHASONE 9% INTRAOCULAR SUSP KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 9 mg daily for 15 days, followed by a stepwise decrease in dosage, plus 300 IU of hMG daily for 10 days
Trial: 9935122
Drug: Placebo, plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, plus 300 IU of hMG daily for 10 days
Trial: 7769049
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group, n = 11)
Trial: 2180233
Drug: Cold-adapted influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-adapted influenza B live attenuated intranasal vaccine
Trial: 31757354
Drug: Cocaine users
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine users with negative drug screen
Trial: 19285833
Drug: Diet containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet containing 25 g of cellulose
Trial: 11463772
Drug: Bromocriptine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (2.5 mg) alone
Trial: 7797824
Drug: pantoprazole (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pantoprazole (40 mg once daily)
Trial: 7797824
Drug: ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine (150 mg b.i.d.)
Trial: 2121268
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g alcohol in concentrations of 75, 180 and 300 ml/l water; RMR measured for 60 min; thermic effect measured for 90 min.
Trial: 2121268
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g alcohol in a 180 ml/l solution plus a meal of food (2 MJ); DIT measured for 240 min.
Trial: 385764
Drug: RIT 4025
RxNorm normalized name: measles virus vaccine live, attenuated Schwarz strain / mumps virus vaccine live, RIT-4385 strain / rubella virus vaccine live (Wistar RA 27-3 strain) Injection [Priorix]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIT 4025 live recombinant strain (10(7.2) EID 50/dose, one or two doses at 2 weeks' interval)
Trial: 385764
Drug: Inactivated vaccine
RxNorm normalized name: diphtheria toxoid vaccine, inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated vaccine (360 i.u. A/Port Chalmers/1/73 (H3N2), 300 i.u. A/Scotland/840/74 (H3N2), 300 i.u. B/Hong Kong/8/73, 300 i.u./dose, one injection)